Key facts
- Ikarian Capital, LLC filed SCHEDULE 13G for Connect Biopharma Holdings Limited Ordinary Shares, par value $0.000174 per Share (CNTB).
- Disclosed ownership: 8.8%.
- Date of event: 31 Dec 2025.
Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G Report for Connect Biopharma Holdings Limited Ordinary Shares, par value $0.000174 per Share (CNTB)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- CNTB
- Shares outstanding
- 56,057,795 shares
- Disclosed Ownership
- 4,933,086 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Feb 2026, 17:22:24 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Key filing fact
Ikarian Capital, LLC disclosed 8.8% ownership in Connect Biopharma Holdings Limited Ordinary Shares, par value $0.000174 per Share (CNTB) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 17:22.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 8.8% | 4,933,086 | 0 | 4,933,086 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 8.8% | 4,933,086 | 0 | 4,933,086 | /s/ Neil Shahrestani | Neil Shahrestani |
CIK / CUSIP context first